One of the lead scientists behind the University of Queensland’s molecular clamp vaccine technology says it could be as good or better than mRNA vaccines, as it heads into phase I clinical trials.
Project leader, Associate Professor Keith Chappell, said the early results suggested their clamp 2.0 vaccine was just as good as version 1.0 and had advantages over mRNA vaccines. “Also transport – it requires simple refrigeration rather than the minus 80 degrees required for some mRNA vaccines.” Participants need to be healthy, aged between 18 and 50, and have had at least two shots of a COVID-19 vaccine but not had a jab or a case of COVID-19 in the past six months.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: